Navigation Links
Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials

EO commented "I am delighted to report such positive results, which confirm the therapeutic and commercial potential of ACE393. This important outcome for ACE BioSciences validates our approach and preclinical work and keeps us on track to launch ACE393 in 2010. In September last year, we entered a collaborative development agreement with the US Naval Medical Research Center (NMRC) to progress ACE393 through Phase II clinical trials and we are about to initiate the first of these studies. These are exciting times for ACE BioSciences in a transformational year for the company."

72 healthy subjects participated in the trial which was undertaken at the Mediscis Phase I clinical unit in Poitiers, France. ACE BioSciences will continue to monitor those patients who received the vaccine at three monthly intervals to evaluate the longevity of the immune response. The full results of the study will be presented by Dr Michael Darsley, Chief Development Officer at ACE BioSciences at the Vaccines for Enteric Diseases Conference, held in Portugal on 25-27 April 2007.

TD is the most frequent health problem in travellers from industrialized countries visiting developing countries. Recent research undertaken by Beremans Ltd in the US and UK, indicates that an effective Campylobacter vaccine for Traveller's Diarrhoea might be purchased by over two million travellers per year and ACE BioSciences estimates that this annual global market would be worth _350 million. The company aims to claim a substantial share of the market by providing the first effective commercial Campylobacter vaccine that delivers good protection and low side effect risk.

Notes for Editors

About Travellers Diarrhoea

Campylobacter jejuni is a bacterium that is one of the main causes of travellers_ diarrhoea. In addition to the disruption it causes to business and holiday travellers, infection is a significant issue for the military and among the 140,000 US military perso
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
2. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
6. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
7. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
8. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
9. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
10. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
11. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
Post Your Comments:
(Date:12/14/2009)... Tenn., Dec. 14 Embarrassing and sometimes uncomfortable ... National researchers are taking note of a new ... approval process. The Knoxville-based company, EDP Biotech ... revolutionary, ColoMarker, an affordable medical device doctors can use ... sample. "When you consider that 30% of colon ...
(Date:12/14/2009)... 14 Following is a statement by ... Healthcare Products Association (CHPA), regarding today,s release of ... the Future survey: ,, "Findings released today on ... the need for continued efforts to educate and ... talk to their teens about medicine abuse. The ...
(Date:12/14/2009)... Perry Baromedical, international leader in Hyperbaric Chamber manufacturing ... Sigma Elite, with extended patient data capture capability. ... available on each monoplace chamber model currently available ... ,, The Sigma Elite New "Smart Hyperbaric System" ... for Each Dive Electronic (EMR) Medical ...
Breaking Medicine Technology:EDP Biotech Takes Next Step in the Development of ColoMarker 2EDP Biotech Takes Next Step in the Development of ColoMarker 3Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 3Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2Clipa for a Cure 3A New Pink Instant Handbag Hanger Benefits Breast Cancer Research 58508 1Clipa for a Cure 3A New Pink Instant Handbag Hanger Benefits Breast Cancer Research 58508 2BASF Podcast 3A The Chemical Reporter Why Does Fluoride Make Your Teeth Hard 3F 58504 1BASF Podcast 3A The Chemical Reporter Why Does Fluoride Make Your Teeth Hard 3F 58504 2BASF Podcast 3A The Chemical Reporter Why Does Fluoride Make Your Teeth Hard 3F 58504 3General Practitioners Write Most Prescriptions for Mental Health Drugs According to Study from Thomson Reuters and SAMHSA 5081 1General Practitioners Write Most Prescriptions for Mental Health Drugs According to Study from Thomson Reuters and SAMHSA 5081 2
(Date:12/14/2009)... Dec. 14 United Dental Care (also known ... the providers of top-notch dental care in Southern California. ... dentistry, kid,s dentistry, braces (orthodontics) and periodontal treatments. ... Dentist offices are staffed with experienced and trusted ... ,, Dr. Eftekhari (Dr. E) is one of these ...
(Date:12/14/2009)... Staff , ... La Jolla, Calif. (Vocus) -- The ... MD, as the new chief of staff of the 372-bed facility. ... team on Jan. 1, 2010. , , , , ,During his ... Scripps La Jolla’s administrative staff and its board of directors. Dr. ...
(Date:12/14/2009)... -- Grubb & Ellis Healthcare REIT II, Inc. announced today ... to stockholders of record as of the close of business ... 2010 and ending on Feb. 28, 2010. The distributions ... year and will be equal to an annualized distribution rate ... share. These distributions will be aggregated and paid in ...
(Date:12/14/2009)... estimated 29,000 future cancers could be linked to scans performed ... Commonly performed CT scans are exposing patients to far more ... tens of thousands of cancers a year, two new studies ... 14/28 issue of the Archives of Internal Medicine , ... Rita F. Redberg, are calling on clinicians to limit radiation ...
(Date:12/14/2009)... highly stigmatized, according to psychiatrists Charles F. Zorumski, ... these Washington University physicians have written a book ... Zorumski and Rubin, who have more than 50 ... patient families, say some of the problems related ... lack of understanding psychiatry and what psychiatrists can ...
Breaking Medicine News(10 mins):Health News:United Dental Care, Gentle Care, Trusted Dentists 2Health News:United Dental Care, Gentle Care, Trusted Dentists 3Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3
... have discovered that mice lacking an enzyme that ... schizophrenia-like behaviors. The finding raises the possibility that ... schizophrenia and related psychiatric disorders and therefore may ... , The BACE1 enzyme, for beta-site amyloid precursor ...
... Central Texas to Receive this Honor, AUSTIN, Texas, ... Foundation announced today that the hospital network was,selected as ... Performance,Excellence, the highest honor bestowed by the State of ... given by the Quality Texas Foundation, is based on ...
... Dermatologic Society (WDS) will provide free, skin cancer screenings and ... ... outreach, CLIFTON, N.J., May 8 As skin cancer continues as ... re-doubled its efforts to spread the message about proper skin,care among outdoor ...
... could also treat other psychiatric disorders , , THURSDAY, ... a computer-assisted training program, in addition to traditional ... counseling alone, a Yale University School of Medicine ... 77 people who sought treatment for drug and ...
... with confidence, recommend a six-month follow-up diagnostic mammogram ... probably benign breast lesions, a new study emphasizes. ... examinations had an 83% sensitivity, which is similar ... Erin J. Aiello Bowles, MPH, lead author of ...
... Training and Launch Meeting - ... May 19, 2008 -, ADDISON, Texas, May 8 ULURU ... Altrazeal(TM) and the,commercial availability of the product commencing the week of ... developed from our,nanoparticle aggregate technology. It is an easy to apply ...
Other Medicine News:Health News:Hopkins researchers discover new link to schizophrenia 2Health News:St. David's HealthCare Granted the State's Top Honor for Quality and Performance Excellence 2Health News:St. David's HealthCare Granted the State's Top Honor for Quality and Performance Excellence 3Health News:New Jersey Dermatologists Gear Up for Fifth Season of 'Play Safe in the Sun' at LPGA's Sybase Classic to Urge Outdoor Enthusiasts to Protect Skin 2Health News:New Jersey Dermatologists Gear Up for Fifth Season of 'Play Safe in the Sun' at LPGA's Sybase Classic to Urge Outdoor Enthusiasts to Protect Skin 3Health News:Computer Program Helps Drug Abusers Stay Clean 2Health News:6-month follow-up diagnostic mammograms recommended for women with probably benign lesions 2Health News:ULURU Inc. Announces the Launch Plan for Altrazeal(TM) 2Health News:ULURU Inc. Announces the Launch Plan for Altrazeal(TM) 3
... frames. They are made of optical quality acrylic and ... are two sets available providing a full range of ... a patient can wear the prism with the trial ... to adapt to the use of the prism. Patient ...
Developed for reconstructive plastic surgery with E-Type coupling. Order blades by size from 12 mm, 25 mm, 50 mm or 75 mm depending on your specific case requirements. Blades come in packs of 10....
Corneal rust ring remover battery powered, extra burr 1.0 mm....
BD Visitec IOL Manipulator (Lester), 0.25 mm diameter tip angled 45 in, 10 mm from end (3/bx, 1 bx/ca), sterile. For positioning intraocular lenses. Sure grip handles hand ridge indicating position o...
Medicine Products: